Literature DB >> 2774120

Effect of single-dose omeprazole on intragastric acidity and volume during obstetric anaesthesia.

J Moore1, R J Flynn, M Sampaio, C M Wilson, K R Gillon.   

Abstract

Various antacid or antisecretory agents are used to reduce the risk to patients of aspiration of gastric contents during general anaesthesia and a trial of the gastric proton pump inhibitor, omeprazole, is reported here. Twenty women admitted for elective Caesarean section under general anaesthesia received a single 80-mg oral omeprazole dose at 2000 hours on the evening before surgery. Intragastric pH and volume were measured immediately after induction of anaesthesia and on completion of surgery. Eighty-five percent of pH measurements at induction and extubation and 80% and 95% of volume measurements at induction and extubation respectively met the defined success criteria (pH greater than or equal to 2.5, volume less than 25 ml). Omeprazole treatment was well tolerated by the women and Apgar scores and subsequent progress of the babies were acceptable. These results indicate that gastric acidity and volume were acceptable in the majority of women after omeprazole treatment, but the interval from drug administration to induction of anaesthesia may have been too long in some cases and resulted in unacceptably low pHs.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2774120     DOI: 10.1111/j.1365-2044.1989.tb11441.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  9 in total

1.  The safety of fetal exposure to proton-pump inhibitors during pregnancy.

Authors:  I Matok; A Levy; A Wiznitzer; E Uziel; G Koren; R Gorodischer
Journal:  Dig Dis Sci       Date:  2011-10-30       Impact factor: 3.199

2.  Gastroesophageal Reflux Disease in Pregnancy.

Authors:  Mohan Charan; Philip O. Katz
Journal:  Curr Treat Options Gastroenterol       Date:  2001-02

3.  Intrauterine exposure to omeprazole increases the risk of teeth morphological anomalies in the offspring of a murine model.

Authors:  Márjori Frítola; Camila Salvador Sestario; Caio Cezar Nantes Martins; Bruna Santos Ezequiel; Juliano Morimoto; Maria José Sparça Salles
Journal:  Odontology       Date:  2022-10-01       Impact factor: 2.885

4.  Use of proton pump inhibitors during pregnancy and rates of major malformations: a meta-analysis.

Authors:  Shekoufeh Nikfar; Mohammad Abdollahi; Myla E Moretti; Laura A Magee; Gideon Koren
Journal:  Dig Dis Sci       Date:  2002-07       Impact factor: 3.199

Review 5.  Interventions at caesarean section for reducing the risk of aspiration pneumonitis.

Authors:  Shantini Paranjothy; James D Griffiths; Hannah K Broughton; Gillian Ml Gyte; Heather C Brown; Jane Thomas
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 6.  Treating gastro-oesophageal reflux disease during pregnancy and lactation: what are the safest therapy options?

Authors:  C N Broussard; J E Richter
Journal:  Drug Saf       Date:  1998-10       Impact factor: 5.606

7.  A comparison of intravenous ranitidine and omeprazole on gastric volume and pH in women undergoing emergency caesarean section.

Authors:  A Tripathi; M Somwanshi; B Singh; P Bajaj
Journal:  Can J Anaesth       Date:  1995-09       Impact factor: 5.063

Review 8.  Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders.

Authors:  M I Wilde; D McTavish
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

9.  Proton-pump inhibitor omeprazole attenuates hyperoxia induced lung injury.

Authors:  Jute Richter; Julio Jimenez; Taro Nagatomo; Jaan Toelen; Paul Brady; Thomas Salaets; Flore Lesage; Jeroen Vanoirbeek; Jan Deprest
Journal:  J Transl Med       Date:  2016-08-27       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.